CHEMOCENTRYX INC (CCXI)

US16383L1061 - Common Stock

51.99  +0.03 (+0.06%)

After market: 51.99 0 (0%)

News Image
a year ago - Amgen

AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX

/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced acquisition of ChemoCentryx, Inc. (NASDAQ:...

News Image
a year ago - ChemoCentryx, Inc.

ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings

-- Planned posters and an oral presentation will highlight data from the trials that supported the approval of TAVNEOS® (avacopan) for patients with...

News Image
1 years ago - ChemoCentryx, Inc.

ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting

-- Two poster presentations planned for CCX559, including results from ongoing Phase I clinical study in patients with advanced solid tumors, and...

News Image
2 years ago - Investor's Business Daily

Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year

The biotech run off a June bottom is great — until you realize you could've netted more.

News Image
2 years ago - Investor's Business Daily

Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin

The market is struggling, yet biotech stocks are acting like it's good times again. Here's why.

News Image
2 years ago - Halper Sadeh LLP

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CYBE, CCXI, AVLR

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
2 years ago - InvestorPlace

7 Dow Stocks With Superior Fundamentals

Robust Dow stocks offer attractive deals for patient investors amidst an unstable economic environment

News Image
2 years ago - Market News Video

ChemoCentryx Larger Than S&P 500 Component PVH

News Image
2 years ago - Halper Sadeh LLP

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates CCXI, HIL, CSVI, AERI

/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
2 years ago - Investor's Business Daily

10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others

These names are benefitting from M&A, clinical data and promising regulatory actions.

News Image
2 years ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates ONEM, CCXI, AERI, SFT

/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
2 years ago - Weiss Law

SHAREHOLDER ALERT: Weiss Law Reminds, LOTZ, GMTX, AAWW, and CCXI Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

News Image
2 years ago - ChemoCentryx, Inc.

ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences

SAN CARLOS, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced planned poster presentations at three upcoming...

News Image
2 years ago - Investor's Business Daily

Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For $770 Million

The biopharma buying spree continued Tuesday with glaucoma drugs maker Aerie.

News Image
2 years ago - Weiss Law

SHAREHOLDER ALERT: Weiss Law Reminds CCXI, HNGR, U, and IRBT Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

News Image
2 years ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates AAWW, CCXI, IRBT

/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
2 years ago - Weiss Law

SHAREHOLDER ALERT: Weiss Law Reminds AAWW, CCXI, HNGR, and U Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

News Image
2 years ago - ChemoCentryx, Inc.

ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call

SAN CARLOS, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the cancellation of its second quarter 2022...

News Image
2 years ago - Investor's Business Daily

Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review

The Nasdaq and small caps rose while the S&P 500 is hitting resistance.

News Image
2 years ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates AAWW, CCXI, IRBT, RADA

/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...